Cardiovascular Safety of 5Ht1B/1D Agonists—Is There a Cause for Concern?
- 1 October 1998
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 18 (8) , 539-545
- https://doi.org/10.1046/j.1468-2982.1998.1808539.x
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- How does sumatriptan nasal spray perform in clinical practice?Cephalalgia, 1998
- Chest Symptoms after SumatriptanCephalalgia, 1996
- 5‐HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5‐HT and sumatriptan with rizatriptan and L‐741,519British Journal of Clinical Pharmacology, 1996
- Effects of S20749, a Close Analogue of Sumatriptan, on Porcine Carotid Haemodynamics and Human Isolated Coronary ArteryBasic & Clinical Pharmacology & Toxicology, 1996
- SumatriptanDrugs, 1994
- Altered esophageal pain threshold in irritable bowel syndromeDigestive Diseases and Sciences, 1993
- Long-Term Experience with Sumatriptan in the Treatment of MigraineEuropean Neurology, 1993
- SumatriptanDrugs, 1992
- Graded esophageal balloon distentionDigestive Diseases and Sciences, 1986
- Psychological comparison of patients with nutcracker esophagus and irritable bowel syndromeDigestive Diseases and Sciences, 1986